BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BBO-10203 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BBO-10203\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06917079-2280@assetmemo.bio
DTSTAMP:20261121T005643Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:BBO-10203: Phase 1 readout est. (NCT06917079)
DESCRIPTION:BBO-10203\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: BBO-1
 1818 in Adult Subjects With KRAS Mutant Cancer\nEstimated primary completi
 on: August 2027. This is a ClinicalTrials.gov estimate\, not a confirmed r
 eadout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/bbo-
 10203#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/N
 CT06917079
URL:https://assetmemo.bio/drug/bbo-10203#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06625775-2280@assetmemo.bio
DTSTAMP:20261121T005643Z
DTSTART;VALUE=DATE:20281130
DTEND;VALUE=DATE:20281201
SUMMARY:BBO-10203: Phase 1 readout est. (NCT06625775)
DESCRIPTION:BBO-10203\, phase 1\, HR+/HER2- Metastatic Breast Cancer.\nStud
 y: Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors\nE
 stimated primary completion: November 2028. This is a ClinicalTrials.gov e
 stimate\, not a confirmed readout date\, and it can move.\nDrug page: http
 s://assetmemo.bio/drug/bbo-10203#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT06625775
URL:https://assetmemo.bio/drug/bbo-10203#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06343402-2280@assetmemo.bio
DTSTAMP:20261121T005643Z
DTSTART;VALUE=DATE:20310430
DTEND;VALUE=DATE:20310501
SUMMARY:BBO-10203: Phase 1 readout est. (NCT06343402)
DESCRIPTION:BBO-10203\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: Open-
 label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lun
 g Cancer\nEstimated primary completion: April 2031. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/bbo-10203#upcoming-events\nRegistry record:
  https://clinicaltrials.gov/study/NCT06343402
URL:https://assetmemo.bio/drug/bbo-10203#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
